PCM
BEAT

Penserra Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Penserra Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,108
Closed -$651K – 836
2018
Q3 		$651K Buy
+10,108
New +$564K 0.04% 246
2017
Q2 		– Sell
-40,032
Closed -$1.16M – 617
2017
Q1 		$1.16M Buy
+40,032
New +$992K 0.12% 76

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Penserra Capital Management's BEAT Position: Q4 2018 in Review

Penserra Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 10,108 shares — an estimated $651K sold.

Penserra Capital Management first reported a position in BEAT in Q1 2017 and held it in 2 quarters. The position peaked at $1.16M in Q1 2017. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Penserra Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
  • Penserra Capital Management sold 10,108 BioTelemetry, Inc. shares in Q4 2018, an estimated $651K.
  • Penserra Capital Management first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 2 quarters.
  • Penserra Capital Management's BioTelemetry, Inc. position peaked at $1.16M in Q1 2017.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Penserra Capital Management's 13F filing for Q4 2018, filed 6 Feb 2019.